Drugs / CYCLO 3 ® FORT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02907320 | Dec 2016 → May 2018 | chronic venous insufficiency | Pierre Fabre Laboratories | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CYCLO 3 FORT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02907320 ↗ |